260 related articles for article (PubMed ID: 26253304)
1. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.
van Hees F; Saini SD; Lansdorp-Vogelaar I; Vijan S; Meester RG; de Koning HJ; Zauber AG; van Ballegooijen M
Gastroenterology; 2015 Nov; 149(6):1425-37. PubMed ID: 26253304
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
[TBL] [Abstract][Full Text] [Related]
3. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
Ladabaum U; Mannalithara A; Mitani A; Desai M
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
[TBL] [Abstract][Full Text] [Related]
5. Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.
Meester RGS; Peterse EFP; Knudsen AB; de Weerdt AC; Chen JC; Lietz AP; Dwyer A; Ahnen DJ; Siegel RL; Smith RA; Zauber AG; Lansdorp-Vogelaar I
Cancer; 2018 Jul; 124(14):2974-2985. PubMed ID: 29846942
[TBL] [Abstract][Full Text] [Related]
6. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.
van Hees F; Habbema JD; Meester RG; Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG
Ann Intern Med; 2014 Jun; 160(11):750-9. PubMed ID: 24887616
[TBL] [Abstract][Full Text] [Related]
7. Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.
Dinh TA; Alperin P; Walter LC; Smith R
J Gen Intern Med; 2012 Jun; 27(6):730-8. PubMed ID: 22237663
[TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.
Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I
Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616
[TBL] [Abstract][Full Text] [Related]
9. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.
Javadinasab H; Daroudi R; Salimzadeh H; Delavari A; Vezvaie P; Malekzadeh R
Arch Iran Med; 2017 Sep; 20(9):564-571. PubMed ID: 29048918
[TBL] [Abstract][Full Text] [Related]
11. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
Ladabaum U; Mannalithara A; Meester RGS; Gupta S; Schoen RE
Gastroenterology; 2019 Jul; 157(1):137-148. PubMed ID: 30930021
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
15. Should colorectal cancer screening start at different ages for men and women? Cost-effectiveness analysis for a resource-constrained service.
Thomas C; Mandrik O; Whyte S; Saunders CL; Griffin SJ; Usher-Smith JA
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1344. PubMed ID: 33533190
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors.
Gini A; Meester RGS; Keshavarz H; Oeffinger KC; Ahmed S; Hodgson DC; Lansdorp-Vogelaar I
J Natl Cancer Inst; 2019 Nov; 111(11):1161-1169. PubMed ID: 30980665
[TBL] [Abstract][Full Text] [Related]
17. Individualizing colonoscopy screening by sex and race.
Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Boer R; Wilschut J; Winawer SJ; Habbema JD
Gastrointest Endosc; 2009 Jul; 70(1):96-108, 108.e1-24. PubMed ID: 19467539
[TBL] [Abstract][Full Text] [Related]
18. Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.
Naber SK; Kuntz KM; Henrikson NB; Williams MS; Calonge N; Goddard KAB; Zallen DT; Ganiats TG; Webber EM; Janssens ACJW; van Ballegooijen M; Zauber AG; Lansdorp-Vogelaar I
Gastroenterology; 2018 Jan; 154(1):105-116.e20. PubMed ID: 28964749
[TBL] [Abstract][Full Text] [Related]
19. The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study.
van Hees F; Zauber AG; Klabunde CN; Goede SL; Lansdorp-Vogelaar I; van Ballegooijen M
JAMA Intern Med; 2014 Oct; 174(10):1568-76. PubMed ID: 25133641
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia.
Naber SK; Almadi MA; Guyatt G; Xie F; Lansdorp-Vogelaar I
Saudi J Gastroenterol; 2021; 27(4):208-216. PubMed ID: 33835054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
